SCHEMBL579287

SCHEMBL579287

CCCCNS(=O)(=O)c1ccc(Cl)nc1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.61
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
ALDH1A1 P00352 6/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
LMNA P02545 3/20 0.54
HTT P42858 3/20 0.54
PKM P14618 1/20 0.54
MAPT P10636 2/20 0.53
CYP2C19 P33261 2/20 0.51
KDM4E B2RXH2 1/20 0.48
ALOX12 P18054 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPK1 P28482 1/20 0.46
TSHR P16473 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6701189 0.83 MEN1 (0.62) GAAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL2992010 0.81 GAA (0.64) GAAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL13296438 0.80 TSHR (0.63) GAAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL4061712 0.80 TSHR (0.68) GAAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL2570435 0.79 LMNA (0.57) GAAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL5712121 0.76 MEN1 (0.57) GAAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL3258566 0.76 MAPT (0.54) GAAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL2997310 0.76 GAA (0.62) GAAMEN1KMT2AALDH1A1LMNA
SCHEMBL2566837 0.76 ALDH1A1 (0.59) GAAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL13314764 0.76 TSHR (0.61) GAAMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4028385-A1 USP30 INHIBITORS AND USES THEREOF Vincere Biosciences, Inc. (US) 2022-07-20 EP disclosed
WO-2021050992-A1 USP30 INHIBITORS AND USES THEREOF VINCERE BIOSCIENCES, INC. (US) 2021-03-18 WO disclosed
EP-2417122-A1 INDOLE DERIVATIVES AND METHODS FOR ANTIVIRAL TREATMENT PTC Therapeutics, Inc. (US) 2012-02-15 EP disclosed
WO-2010117932-A1 INDOLE DERIVATIVES AND METHODS FOR ANTIVIRAL TREATMENT SCHERING CORPORATION (US) 2010-10-14 WO disclosed